Pacer Data & Infra Real Estate ETF vs TransMedics Group Inc — how do they compare? Pacer Data & Infra Real Estate ETF trades at $28.88 (market cap $296.73M), while TransMedics Group Inc trades at $79.03 (market cap $2.74B). The key difference: TransMedics Group Inc is far larger — about 9.2× Pacer Data & Infra Real Estate ETF's market cap, and TransMedics Group Inc is more actively traded (949,331 versus 243,654). Which is the better fit depends on your goals — on Pluang, investors hold Pacer Data & Infra Real Estate ETF for 10 Days and TransMedics Group Inc for 24 Days on average.
| SRVR | TMDX | |
|---|---|---|
Market Cap | $296.73M | $2.74B |
Volume | 243,654 | 949,331 |
Sector | Sector/Thematic | Health |
52-Week High | $35.74 | $150.42 |
52-Week Low | $28.17 | $61.99 |
Typical Hold Time | 10 Days | 24 Days |
Enterprise Value | — | $3.13B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
TransMedics Group (TMDX) trades at $80.69, down 0.47% on the day, amid a bearish technical signal and mixed earnings performance. The company reported strong revenue growth to $605.49M in 2025 with a net income margin of 22.69%, but recent quarters have seen earnings misses. Analyst sentiment remains positive with a consensus price target of $99.75 and a 69% buy rating, though news flow includes investigations into fiduciary duties.
The outlook balances robust fundamentals against near-term headwinds. Upside potential exists from the high analyst target and strong profitability metrics like a 36.28% ROE, but risks include earnings volatility, margin pressure, and ongoing legal scrutiny. The stock's current valuation at a P/E of 20.47 offers a reasonable entry if execution improves.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Pacer Data & Infra Real Estate ETF seeks exposure to real estate companies that own digital infrastructure assets. Its holdings may include data centers, cell towers, fiber networks, and other connectivity-related real estate.
Read more on SRVR →TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →